Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.93 EUR | -1.08% | -2.21% | -22.97% |
11:55am | Bayer: further positive results in menopause | CF |
10:10am | Bayer's Elinzanetant Reduces Menopausal Symptoms in Late-stage Trial | MT |
Evolution of the average Target Price on Bayer AG
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Bayer AG
BERENBERG | Sebastian Bray |
DZ BANK | Peter Spengler |
alphavalue | Martin Schnee |
DEUTSCHE BANK RESEARCH | Falko Friedrichs |
BERNSTEIN RESEARCH | Gunther Zechmann |
BARCLAYS | Emily Field |
UBS | Jo Walton |
JPMORGAN | Richard Vosser |
JEFFERIES | Charlie Bentley |
Stifel Nicolaus | |
MORGAN STANLEY | Thibault Boutherin |
CREDIT SUISSE | Dominic Lunn |
GOLDMAN SACHS | Keyur Parekh |
DEUTSCHE BANK | Falko Friedrichs |
NORDLB | Thorsten Strauß |
KEPLER CHEUVREUX | Christian Faitz |
WARBURG RESEARCH | Ulrich Huwald |
BRYAN GARNIER | Jean-Jaques Le Fur |
INDEPENDENT RESEARCH | Tobias Gottschalt |
BANK OF AMERICA (BOFA) | Sachin Jain |
BAADER BANK | Markus Mayer |
HSBC | Stephen McGarry |
LIBERUM CAPITAL | Graham Doyle |
SOCIETE GENERALE (SOCGEN) | Florent Cespedes |
EPS Revisions
- Stock
- Equities
- Stock Bayer AG - Xetra
- Consensus Bayer AG